Ontology highlight
ABSTRACT: Objectives
Granulomatosis with polyangiitis (GPA) is a chronic relapsing systemic autoimmune vasculitis. Current treatment of GPA is unsatisfactory, as it relies on strong immunosuppressive regimens, with either CYC or rituximab, which reduce the immunogenicity of several vaccines and are risk factors for a severe form of COVID-19. This emphasizes the need to identify new drug targets and to develop treatment strategies with less harmful side effects. Since CD4+ effector memory T cells (TEM) play a key role in the pathogenesis of GPA, we aimed in this study to modulate CD4+TEM cell activity via Kv1.3 blockade using the specific peptide inhibiter, ShK-186.Methods
Peripheral blood samples from 27 patients with GPA in remission and 16 age- and sex-matched healthy controls (HCs
SUBMITTER: Lintermans LL
PROVIDER: S-EPMC10765141 | biostudies-literature | 2024 Jan
REPOSITORIES: biostudies-literature